Details of issuance or disposal
Monthly exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions)
Shares issued during the month: 6,600 new shares; 0 treasury shares transferred
The lower thin line represents the existing number of shares to which these shares will be added.
0.2% (exercise ratio subject to exercise restrictions; 6,600 shares issued across all series / 2,950,228 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment and exercise suspension provisions) |
| Number of shares to be issued or disposed of | Shares issued during the month: 6,600 new shares; 0 treasury shares transferred |
| Intended allottee | EVO FUND (issued on 4 December 2025) |
| Dilution Rate | 0.2% (exercise ratio subject to exercise restrictions; 6,600 shares issued across all series / 2,950,228 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 3,341,728 shares (as of the end of the month preceding the month under review, including 3,616 treasury shares) → Not disclosed |
| Exercise price | The exercise price during the month under review ranged from ¥337 to ¥387. Details of the exercise-price adjustment provisions and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 10,000; exercised during the month under review: 66; unexercised as of the end of the preceding month: 6,085; unexercised as of month-end: 6,019 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 4 December 2025 / Type Issuance of the 18th Stock Acquisition Rights allocated to EVO FUND / Amount Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the stock acquisition rights.